Abstract:Objective To investigate modeling drugs in animal models of chronic bronchitis (CB) and provide a reference for experimental method and model refinement of this animal model. Methods Using chronic bronchitis and animal models as subject terms, literature related to animal models of chronic bronchitis from January 2000 to January 2022 was collected from the China Knowledge Network, Wanfang database, and PubMed database. The model animal species, modeling method , test indexes, positive control drugs, administration time, and evidence of modelling in the literature were collated and summarized to establish a database for statistical analysis. Results We screened out 243 articles that met the criteria. SD rats (126, 51. 85%) were the most common animal species, followed by Wistar rats (70, 28. 81%) and Kunming mice (30, 12. 35%). The gender of the animals was mostly male (120, 49. 38%). The modeling method was mostly smoking (111, 46. 91%), followed by intratracheal injection of lipopolysaccharide (LPS) combined with smoking (44, 18. 11%). LPS was mostly injected into the trachea (43, 17. 70%), and the modeling cycle was mostly 20 ~ 30 days (146, 60. 08%). The commonly used test indicators were bronchopulmonary histopathology (143, 20. 82%), serum (99, 14. 41%), bronchoalveolar lavage fluid (82, 11. 93%), and general condition (66, 9. 61%). Among the 131 articles with positive control drugs, the most used was Guilong Cough and Panning Capsules (30, 21. 58%), followed by dexamethasone acetate (28, 20. 14%). Animal models of Chinese medicine syndrome had 10 pulmonary qi deficiency syndrome and one pulmonary yin deficiency syndrome. Conclusions The current CB animal models are mostly established by a single-factor fumigation method and LPS intratracheal injection combined with fumigation. The model animals are SD/Wistar rats or Kunming mice, and the modeling period is mostly within 20 ~ 30 days, which effectively improves the experimental efficiency. The evaluation criteria of the model are mostly combined with bronchopulmonary histopathology, general condition, serum, alveolar lavage fluid, and other indicators for comprehensive judgment. We should focus on establishment of animal models for CB by developing unified and standardized modeling criteria and relevant model evaluation indicators to establish more reasonable animal models of CB.